chr10-100152307-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006459.4(ERLIN1):āc.871A>Gā(p.Ile291Val) variant causes a missense change. The variant allele was found at a frequency of 0.422 in 1,611,308 control chromosomes in the GnomAD database, including 158,534 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.32 ( 10029 hom., cov: 32)
Exomes š: 0.43 ( 148505 hom. )
Consequence
ERLIN1
NM_006459.4 missense
NM_006459.4 missense
Scores
2
14
Clinical Significance
Conservation
PhyloP100: 5.93
Genes affected
ERLIN1 (HGNC:16947): (ER lipid raft associated 1) The protein encoded by this gene is part of a protein complex that mediates degradation of inositol 1,4,5-trisphosphate receptors in the endoplasmic reticulum. The encoded protein also binds cholesterol and regulates the SREBP signaling pathway, which promotes cellular cholesterol homeostasis. Defects in this gene have been associated with spastic paraplegia 62. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0010764897).
BP6
Variant 10-100152307-T-C is Benign according to our data. Variant chr10-100152307-T-C is described in ClinVar as [Benign]. Clinvar id is 1167054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.474 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ERLIN1 | NM_006459.4 | c.871A>G | p.Ile291Val | missense_variant | 11/11 | ENST00000421367.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ERLIN1 | ENST00000421367.7 | c.871A>G | p.Ile291Val | missense_variant | 11/11 | 1 | NM_006459.4 | P1 | |
ERLIN1 | ENST00000407654.7 | c.871A>G | p.Ile291Val | missense_variant | 12/12 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.322 AC: 48963AN: 152068Hom.: 10031 Cov.: 32
GnomAD3 genomes
AF:
AC:
48963
AN:
152068
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.335 AC: 84196AN: 251116Hom.: 17313 AF XY: 0.339 AC XY: 46043AN XY: 135718
GnomAD3 exomes
AF:
AC:
84196
AN:
251116
Hom.:
AF XY:
AC XY:
46043
AN XY:
135718
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.433 AC: 631454AN: 1459122Hom.: 148505 Cov.: 33 AF XY: 0.427 AC XY: 309690AN XY: 726030
GnomAD4 exome
AF:
AC:
631454
AN:
1459122
Hom.:
Cov.:
33
AF XY:
AC XY:
309690
AN XY:
726030
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.322 AC: 48951AN: 152186Hom.: 10029 Cov.: 32 AF XY: 0.313 AC XY: 23317AN XY: 74398
GnomAD4 genome
AF:
AC:
48951
AN:
152186
Hom.:
Cov.:
32
AF XY:
AC XY:
23317
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1872
ALSPAC
AF:
AC:
1913
ESP6500AA
AF:
AC:
460
ESP6500EA
AF:
AC:
4044
ExAC
AF:
AC:
40348
Asia WGS
AF:
AC:
411
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 24, 2021 | - - |
Hereditary spastic paraplegia 62 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
P;P
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Vest4
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at